Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mitsubishi Tanabe Pharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mitsubishi Tanabe Pharma's 2012 Japan sales performance.

Mitsubishi Tanabe Pharma Corporation

Cortellis Drugs to Watch in 2020 report

Cortellis Drugs to Watch in 2020 report

4. Vadadustat is an inhibitor of hypoxiainducible factor (HIF)-prolyl hydroxylase (HIF-PH) from Akebia Therapeutics/ Mitsubishi Tanabe Pharma/Otsuka that targets anaemia in chronic kidney disease (CKD).

GSK files anaemia drug daprodustat in Japan, its first market

GSK files anaemia drug daprodustat in Japan, its first market class called vadadustat in late-stage clinical testing that is licensed to Mitsubishi Tanabe Pharma in some Asian markets including Japan.

Voice biomarker device could diagnose depression, heart disease

Voice biomarker device could diagnose depression, heart disease The financing round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), with MP Healthcare Venture Management (the corporate venture capital arm of Mitsubishi Tanabe

Biogen picks up another drug from wide-ranging Ionis alliance

Biogen picks up another drug from wide-ranging Ionis alliance It was joined last year by Mitsubishi Tanabe Pharma’s Radicava/Radicut (edaravone) last year, which provides another options, but there is still a desperate need for additional therapies.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn Japan's Mitsubishi Tanabe Pharma has boosted its pipeline with a $1.1bn deal to buy NeuroDerm, an Israeli developer of central nervous system therapies. ... Adding ND0612 into the portfolio will help Mitsubishi meet its target of driving US sales to 80bn

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics